Business NewsPR NewsWire • Slayback Pharma announces the final approval and launch of Generic Zovirax (Acyclovir) Ointment 5%

Slayback Pharma announces the final approval and launch of Generic Zovirax (Acyclovir) Ointment 5%

Slayback Pharma announces the final approval and launch of Generic Zovirax (Acyclovir) Ointment 5%

PRINCETON JUNCTION, N.J., Dec. 23, 2016 /PRNewswire/ -- Slayback Pharma LLC is pleased to announce the launch of Generic Zovirax Ointment (Acyclovir Ointment) 5%, by its out-licensee - Sandoz (Fougera). Slayback had developed the product and out-licensed the sales and marketing rights to...

View More : http://www.prnewswire.com/news-releases/slayback-pharma-announces-the-final-approval-and-launch-of-generic-zovirax-acycl...
Releted News by prnewswire
L'internationalisation de la formation de Tongji SEM est placée sous la stratégie nationale « Une ceinture, une route »
Slayback Pharma announces the final approval and launch of Generic Zovirax (Acyclovir) Ointment 5%